 Features |
Welcome to
OsseoTECH, a site devoted to chronicling osseointegration developments Please send suggestions for features.
|
| Sponsors |
|
| Links |
CDE-Directory - A Comprehensive Guide to Continuing Dental Education
OsseoNews - The World of Implant Dentistry Online
PalmDMD - PDA's in clinical dentistry
Medgadget - Emerging Medical Technologies
PalmDDS - PDA's in clinical dentistry
CurrentJournals - Keeping you updated Automatically - Keywords, Journals, Authors delivered weekly in an easy to read PDF format
|
|
Swedish Medical Products Agency Demands Nobel Biocare Improve Instructions |
Posted by:Editor
on Monday July 9th, 2007
|
The Swedish Medical Products Agency(SMPA) released a demand for Nobel Biocare to improve the instructions for both its NobelDirect and NobelPerfect implants. Previously Nobel Biocare had released a response to the recent marketing ban on their NobelDirect implant following reports that it lost an excessive amount of bone following placement. The SMPA stood by its decision that the firm not be allowed to market the implants until it had carried out the improvement of the instructions. The SMPA stated that the instructional information must be supplemented and further clarified. As an example, the SMPA described Nobel Biocare`s instruction statement: “you don´t have to be a specialist to prepare the site for NobelDirect” as `inappropriate`.
More
 SMPA Assesment of Nobel Biocare`s Response <<< Back  E-Mail This Topic: Implant Design
|
|
 |
! There are no comments posted for this item yet.
| |
